Marek GJ

Gilgamesh Pharmaceuticals Inc., New York, NY, USA.

1 paper · ORCID

ArticlePsilocybin

A novel psychedelic 5-HT<sub>2A</sub> receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.

Marek GJ, Makai-Bölöni S, Umbricht D +16

Europe PMC2026